Recombinant protective antigen vaccines - Primrose Bio
Alternative Names: Glide anthrax vaccine; Px 563L; Px-563L SDI; Px563L-mrPA; RPA 563; rPA anthrax vaccine - Primrose Bio; SDI rPA anthrax vaccine - Primrose BioLatest Information Update: 22 Sep 2023
At a glance
- Originator Pfenex
- Developer IMV; Primrose Bio; US Department of Health and Human Services
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anthrax
Most Recent Events
- 18 Sep 2023 Primordial Genetics has merged with Pelican Expression Technology to form Primrose Bio
- 01 Oct 2020 Pfenex has been acquired by Ligand Pharmaceuticals
- 28 Mar 2019 No recent reports of development identified for phase-I development in Anthrax(Prevention, In volunteers) in USA (IM, Injection)